NCT00163748View on ClinicalTrials.gov

Efficacy and Treatment Related Toxicity Study of a New Regimen for Lymphoma

PHASE2CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

February 28, 2001

Primary Completion Date

November 30, 2003

Study Completion Date

November 30, 2003

Conditions

Non-Hodgkin's LymphomaHodgkin's Disease

Interventions

DRUG

gemcitabine, vinorelbine

Trial Locations (2)

2065

Royal North Shore Hospital, Sydney

3004

The Alfred Hospital, Melbourne

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayside Health

OTHER_GOV